A Study to Evaluate Post-discharge Early Assessment with a Video Visit

Overview

Información sobre este estudio

The purpose of this study is to evaluate whether a video visit with an advanced practice provider (APP (Nurse practitioner or Physician assistant) within 7 days after discharge from Hospital Internal Medicine services at Saint Marys Hospital will increase patient adherence with medication, self-management, and home support post-hospital discharge (primary outcome). We will also evaluate subsequent 7- and 30- day emergency department visits and hospital re-admissions (secondary outcome). Patients enrolled in the study will undergo 1:1 randomization: video-visit + usual care (intervention arm) and usual care (control arm).  Participants in each arm will participate in a telephone survey 4-6 days after hospital discharge reviewing discharge medication and self-management.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Adult patients, ≥ 18 years of age.
  • Patients discharged from a Hospital Internal Medicine service at Saint Marys Hospital to patient's home or assisted living facility.
  • Patients or their legally authorized representative provides consent to participate in the study.

Exclusion Criteria: 

  • Patients discharged from Hospital Service Meds 1-4 and Med 17.
  • Patient discharged with Care Transitions Program, or to Hospice, skilled nursing facility (SNF) or long-term acute care (LTAC) facility.
  • Post-procedure patients (i.e., elective hospital admission for planned intervention or procedure).
  • Patient/legally authorized representative is Non-English speaking.
  • Patient leaves the hospital Against Medical Advice (AMA).
  • No access to mobile technology/laptop/computer for post-discharge follow-up.
  • Patient with an active diagnosis Covid-19 infection.
  • Patients with a scheduled re-admission for a procedure, chemotherapy, or other treatment.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Chandrasagar Dugani, M.D., Ph.D.

Cerrado para la inscripción

Contact information:

Chandrasagar Dugani M.D., Ph.D.

(507) 255-8043

Dugani.Chandrasagar@mayo.edu

Austin, Minn.

Investigador principal de Mayo Clinic

Anne Liwonjo, M.D.

Cerrado para la inscripción

Contact information:

Chandrasagar Dugani M.D., Ph.D.

Dugani.Chandrasagar@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20502319

Mayo Clinic Footer